Academic Journal
Q1Blood Advances
About Blood Advances
Blood Advances is a scholarly journal published by American Society of Hematology. SCImago 2025 lists it in Q1, with an SJR of 3.11 and H-index of 110.
Coverage: 2016-2026. Research categories: Hematology (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML
Naoto Takahashi, Yosuke Minami, Yuki Fujioka, Shigeki Ohtake et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020915Too little, too late? The burden of delayed care in NTDT
Khaled M. Musallam, Thomas D. Coates, Ali T. Taher
2026-09-22 · DOI: 10.1182/bloodadvances.2026021248Anti-CD19 CAR-T in transformed indolent lymphoma vs de novo large B-cell lymphoma: a meta-analysis of 5006 patients
Min-Yue Zhang, Ke-Jie Lu, Xiao-Qing Zhu, Li-Jing Shen et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2025019087AI-derived whole-body MRI metrics in patients with multiple myeloma reveal unique insights into body composition and outcomes
Nicolas Basty, Martin Kaiser, Charlotte Pawlyn, Kevin Boyd et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020852RENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma
Barbara Botto, Carola Boccomini, Andrea Evangelista, Vittorio Ruggero Zilioli et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2025018732Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q
Maria Julia Montoro, Víctor Navarro, Pamela Acha, Claudia Haferlach et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020633Selinexor combined with R-CHOP achieved a high response rate in newly diagnosed double/triple-hit lymphoma
Cong Li, Xi Chen, Jieyu Xu, Tao Lei et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2025018580Selective degradation of platelet BTK by PROTAC NX-5948 provides antithrombotic benefits without affecting hemostasis
Carl J. May, Justin S. Trory, Connor E. Webb, Hetty S. Walker et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026019769Better late than never: risks of late cytopenias after CAR T
Alex Niu, Brian C. Betts
2026-09-22 · DOI: 10.1182/bloodadvances.2026021421Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis
Kitsada Wudhikarn, Maria Bromberg, Jamie Brower, Venkatraman Seshan et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026019953Incidence and risk factors for CNS relapse in adult ALL after allogeneic hematopoietic cell transplantation
Catherine T. Le, Amy Zhang, Rutu D. Vyas, Joanne Otani et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020594Spatial transcriptomics identifies a suppressive, T-cell–excluded tumor microenvironment in extramedullary myeloma
Nicholas E. Bingham, Julie R. Boiko, Daniel C. Jones, Daniel Wong et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020500Seroprotection after measles vaccination in children with sickle cell anemia receiving hydroxyurea
Alexandra Power-Hays, Abigail Kincaid, Kathyrn E. McElhinney, Teresa S. Latham et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026019674Editing around the target: epitope engineering to protect stem cell grafts
Joanne Baek, Gabriele Casirati, Pietro Genovese, Saar Gill et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2025018227Estrogen-associated thrombosis and the road not taken
Arielle L. Langer
2026-09-22 · DOI: 10.1182/bloodadvances.2026021425Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU–induced myeloablation
Tiffany P. Nguyen, Yong G. Jiang, Betul M. Ogan, Andrew D. Doyle et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2025019416Evolution of real-world frontline treatment patterns in multiple myeloma
Alexander Lazzaro, Kaelyn Nannini, Cenk Yildirim, Linden Huhmann et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026019843Sirolimus for refractory/relapsed warm autoimmune hemolytic anemia and Evans syndrome: a prospective study
Qi Wang, Ziwei Liu, Chen Yang, Jian Li et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026019844Delayed recognition and significant morbidity in adults with non–transfusion-dependent thalassemia
Aaron N. Cheng, Scott Peslak, Sujit Sheth, Farzana Sayani et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020059Blood rheology after allogeneic hematopoietic stem cell transplantation or gene therapy in sickle cell disease
Ashwin P. Patel, Tami D. John, Stephen Gottschalk, Brandon M. Triplett et al.
2026-09-22 · DOI: 10.1182/bloodadvances.2026020768Reviews
Community Reviews
Version History
September 15, 2026 at 2:15 am
September 15, 2026